...
首页> 外文期刊>International journal of hyperthermia: The official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group >Thermal ablation of pancreatic cancer: A systematic literature review of clinical practice and pre-clinical studies
【24h】

Thermal ablation of pancreatic cancer: A systematic literature review of clinical practice and pre-clinical studies

机译:胰腺癌的热消融:临床实践和临床前研究的系统文献综述

获取原文
           

摘要

Pancreatic cancer is a challenging malignancy with low treatment option and poor life expectancy. Thermal ablation techniques were proposed as alternative treatment options, especially in advanced stages and for unfit-for-surgery patients. This systematic review describes the thermal ablative techniques -i.e., Laser (LA), Radiofrequency (RFA), Microwave (MWA) Ablation, High-Intensity Focused Ultrasound (HIFU) and cryoablation- available for pancreatic cancer treatment. Additionally, an analysis of the efficacy, complication rate and overall survival for each technique is conducted. This review collects the ex vivo, preclinical and clinical studies presenting the use of thermal techniques in the pancreatic cancer treatment, searched up to March 2018 in PubMed and Medline. Abstracts, letters-to-the-editor, expert opinions, reviews and non-English language manuscripts were excluded. Sixty-five papers were included. For the ex vivo and preclinical studies, there are: 12 records for LA, 8 for RFA, 0 for MWA, 6 for HIFU, 1 for cryoablation and 3 for hybrid techniques. For clinical studies, 1 paper for LA, 14 for RFA, 1 for MWA, 17 for HIFU, 1 for cryoablation and 1 for hybrid techniques. Important technological advances are presented in ex vivo and preclinical studies, as the real-time thermometry, nanotechnology and hybrid techniques to enhance the thermal outcome. Conversely, a lack of standardization in the clinical employment of the procedures emerged, leading to contrasting results on the safety and feasibility of some analyzed techniques. Uniform conclusions on the safety and feasibility of these techniques for pancreatic cancer will require further structured investigation.
机译:胰腺癌是一种具有挑战性的恶性肿瘤,治疗选择率低且预期寿命差。提出了热消融技术作为替代治疗选择,特别是在晚期阶段以及不适合手术的患者。这篇系统的综述描述了可用于胰腺癌治疗的热消融技术-即激光(LA),射频(RFA),微波(MWA)消融,高强度聚焦超声(HIFU)和冷冻消融。另外,对每种技术的功效,并发症发生率和总生存率进行了分析。这篇综述收集了体外研究,临床前研究和临床研究,这些研究提出了热技术在胰腺癌治疗中的应用,这些研究截至2018年3月在PubMed和Medline中进行了检索。摘要,编辑信,专家意见,评论和非英语手稿均不包括在内。包括65篇论文。对于离体和临床前研究,有:LA的12条记录,RFA的8条记录,MWA的0条记录,HIFU的6条记录,冷冻消融的1条记录和混合技术的3条记录。对于临床研究,LA用1张纸,RFA用14张,MWA用1张,HIFU用17张,冷冻消融用1张,混合技术用1张。离体和临床前研究显示了重要的技术进展,例如实时测温,纳米技术和混合技术以增强热结果。相反,出现了在临床使用过程中缺乏标准化的情况,从而导致某些分析技术在安全性和可行性上的对比结果。关于这些技术对胰腺癌的安全性和可行性的一致结论将需要进一步的结构研究。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号